<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02312193</url>
  </required_header>
  <id_info>
    <org_study_id>LMB02</org_study_id>
    <nct_id>NCT02312193</nct_id>
  </id_info>
  <brief_title>Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects</brief_title>
  <official_title>Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuromed IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuromed IRCCS</source>
  <brief_summary>
    <textblock>
      Aim of this study is to enhance the knowledge of myogenic tone alterations in hypertensive
      patients and to better understand the mechanisms controlling the myogenic tone. Evaluations
      will be performed through ex vivo studies of peripheral arterioles in human adipose tissue
      from lumbar muscle, isolated from biopsies. This will allow investigators to evaluate the
      myogenic function in response to progressive blood pressure increases, in order to correlate
      myogenic function to arterial hypertension and to the molecular mechanisms already identified
      in the preclinical models.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myogenic tone measured by micromyographic technique to evaluate small-artery morphology.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">95</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <description>Hypertensive subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Normotensive subjects</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected from patients hospitalized in the Department of Neurosurgery of
        the IRCCS Mediterranean Neurological Institute Neuromed, according to specific inclusion
        criteria and undergoing surgery for disc disease. Subjects included in the study will be
        normotensive and hypertensive patients. Approximately 70 subjects of both genders (35
        normotensive, 35 hypertensive) aged between 30 and 70 years old will be included in the
        study. All the enrolled patients must have an indication for neurosurgical intervention.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females between 30 and 70 years of age

          -  Hypertensive patients: Patients with a previous diagnosis of hypertension

          -  Normotensive patients: subjects without story of hypertension

          -  Written informed consent

        Exclusion Criteria:

          -  Severe hypertension (eg, systolic &gt;180 mm Hg, diastolic &gt;110 mm Hg)

          -  Manifested or suspected secondary hypertension (coarctation of the aorta,
             hyperaldosteronism, unilateral or bilateral renal artery stenosis, pheochromocytoma)

          -  History of cardiac complications (previous acute myocardial infarction (AMI),
             unstabile angina, percutaneous transluminal coronary angioplasty (PTCA), coronary
             artery bypass grafting (CABG), congestive heart failure (NYHA II-IV))

          -  Diabetes mellitus

          -  Renal pathologies (creatinine clearance &lt; 30 ml/min)

          -  Severe hepatic dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giuseppe Lembo, MD, PhD</last_name>
    <phone>+39 0865.915225</phone>
    <email>lembo@neuromed.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Neuromed</name>
      <address>
        <city>Pozzilli</city>
        <state>Isernia</state>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Lembo, MD, PhD</last_name>
      <phone>+39 0865.915225</phone>
      <email>lembo@neuromed.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Lembo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gualtiero Innocenzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giulio Selvetella, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela Carnevale, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2014</study_first_submitted>
  <study_first_submitted_qc>December 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2014</study_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neuromed IRCCS</investigator_affiliation>
    <investigator_full_name>Giuseppe Lembo</investigator_full_name>
    <investigator_title>MD, Ph</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>myogenic tone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

